Slack Technologies Inc (WORK)

45.2  +0.04 (+0.09%)

After market: 45.37 +0.17 (+0.38%)

Fundamental Rating

3

Overall WORK gets a fundamental rating of 3 out of 10. We evaluated WORK against 277 industry peers in the Software industry. The financial health of WORK is average, but there are quite some concerns on its profitability. WORK shows excellent growth, but is valued quite expensive already.



0

1. Profitability

1.1 Basic Checks

In the past year WORK was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -10.45%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -26.91%
PM (TTM) -25.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

There is no outstanding debt for WORK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

WORK has an Altman-Z score of 10.07. This indicates that WORK is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for WORK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.07
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.84 indicates that WORK has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio N/A

8

3. Growth

3.1 Past

WORK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 136.36%, which is quite impressive.
The Revenue has grown by 39.74% in the past year. This is a very strong growth!
WORK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.17% yearly.
EPS 1Y (TTM)136.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q500%
Revenue 1Y (TTM)39.74%
Revenue growth 3Y59.96%
Revenue growth 5Y71.17%
Revenue growth Q2Q35.56%

3.2 Future

WORK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 114.11% yearly.
Based on estimates for the next years, WORK will show a very strong growth in Revenue. The Revenue will grow by 24.65% on average per year.
EPS Next Y808.9%
EPS Next 2Y249.28%
EPS Next 3Y194.18%
EPS Next 5Y114.11%
Revenue Next Year35.55%
Revenue Next 2Y31.36%
Revenue Next 3Y26.69%
Revenue Next 5Y24.65%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 565.00, the valuation of WORK can be described as expensive.
The average S&P500 Price/Earnings ratio is at 28.91. WORK is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 221.57, which means the current valuation is very expensive for WORK.
WORK is valuated expensively when we compare the Price/Forward Earnings ratio to 20.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 565
Fwd PE 221.57

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -146.54

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WORK's earnings are expected to grow with 194.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y249.28%
EPS Next 3Y194.18%

0

5. Dividend

5.1 Amount

WORK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Slack Technologies Inc

NYSE:WORK (7/20/2021, 8:46:58 PM)

After market: 45.37 +0.17 (+0.38%)

45.2

+0.04 (+0.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.52B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 565
Fwd PE 221.57
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.45%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -26.91%
PM (TTM) -25.98%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.84
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)136.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y808.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)39.74%
Revenue growth 3Y59.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y